CAS 1044758-60-2

Etrolizumab

CAS : 1044758-60-2

MEDI-578 is a CHO-expressed humanized monoclonal antibody targeting NGF/bNGF for the study of neurological and immune system disorders.

Degré de pureté : 98.9% (SDS-PAGE); 96.6% (SEC-HPLC) - 98.9% (SDS-PAGE); 96.6% (SEC-HPLC)

Couleur et forme : Liquid

Masse moléculaire : 144.1 kDa

Ref: TM-T77154

Etrolizumab

CAS : 1044758-60-2

Anti-Human α4β7 Monoclonal Antibody

Ref: 3D-CLA1265